Introduction
Malignant gliomas are deadly brain tumors that are invasive and tend to infiltrate into adjacent healthy brain tissues, preventing complete surgical removal, and are resistant to radiological and chemotherapies. To date, factors governing glioma tumor progression and invasion are not completely understood (Chakravarti and Palanichamy, 2008) .
High activity of the canonical transforming growth factor-b (TGF-b) signaling pathway confers poor prognosis and promotes cell proliferation in human gliomas (Wick et al., 2006; Bruna et al., 2007) . Reduction of TGF-b signaling decreased invasiveness and lowered proliferation of glioma cells (Hjelmeland et al., 2004; Uhl et al., 2004) . TGF-b signaling induces leukemia inhibitory factor (LIF) expression, which in turn activates the JAK-STAT pathway in glioma-initiating cells, which may be responsible for the initiation, propagation and recurrence of tumors (Penuelas et al., 2009) . However, Nodal, another member of the TGF-b superfamily, has been shown to have tumorigenic potentials. Nodal is an embryonic morphogen that regulates dorsal mesoderm induction, anterior patterning and left-right asymmetry (Brennan et al., 2002; Nonaka et al., 2002; Smith et al., 2008) . Nodal also has an important role in maintaining pluripotency of human embryonic stem cells and cancer cells (Vallier et al., 2004 (Vallier et al., , 2005 Saha et al., 2008) . Importantly, Nodal secretion mediated plasticity and tumorigenicity of metastatic melanoma and inhibition of Nodal promoted tumor differentiation and regression (Topczewska et al., 2006; Hendrix et al., 2007; Postovit et al., 2008a, b) . The association of Nodal with Cripto-1, a coreceptor, enables binding to type I and type II activin-like kinase receptors and activation of SMAD signaling (Topczewska et al., 2006) . A long-term exposure to the anti-Nodal antibody induced apoptosis in human melanoma lung metastases (Strizzi et al., 2009) . Whether Nodal inhibition affects tumor progression in aggressive glioma has not been addressed.
Malignant glioma cells express certain matrix metalloproteinases (MMPs) that are implicated in regulating invasiveness and angiogenesis in gliomas (Kargiotis et al., 2008) . High levels of MMP-2 expression were found in higher-grade gliomas, and correlated well with the malignancies of human gliomas (Koul et al., 2001) . In addition to MMP-2 secretion, another crucial step for invasion is to gain motility, which enables cancer cells to invade adjacent tissues. Increased expression of the mesenchymal protein vimentin has been linked with the induction of the migratory phenotype in a variety of cancers (Christiansen and Rajasekaran, 2006) . Vimentin, an intermediate filament protein, is upregulated in highly infiltrative gliomas with poor diagnosis (Strojnik et al., 2006; Candolfi et al., 2007) . In addition, malignant progression of neoplastic astrocytes is accompanied with a decrease in glial fibrillary acidic protein (GFAP) expression. GFAP, an intermediate filament protein largely specific for astrocytes, is among the best markers of astrocytic differentiation (Rutka et al., 1997; Zhou and Skalli, 2000) .
In this study, we analyzed the roles of Nodal in proliferation, invasiveness and differentiation of human glioma cells. We show that mice xenografted with human glioma cells bearing ectopically expressed Nodal had significantly shorter lifespan than those of controls. Conversely, mice xenografts of U87MG cells with knockdown of Nodal by specific short hairpin RNA (shRNA) had significantly longer lifespan. Nodal, through ectopic expression or exogenous addition, increased Smad phosphorylation, whereas the Nodalspecific antagonist, SB431542, decreased Nodal-induced Smad phosphorylation. We showed that expressions of LIF, a downstream target of SMAD, and Cripto-1, the Nodal coreceptor, increased in Nodal-transfected cells. Taken together, these results suggest that the expression levels of Nodal correlated well with glioma malignancy both in vitro and in vivo, and that Nodal might be a therapeutic target for the treatment of gliomas.
Results
Nodal expression in human glioma cell lines correlated with cell invasiveness and with tumor growth rates in xenografts To determine whether Nodal has a role in glioma invasion, we compared the expression levels of Nodal in U87MG cells and two other cell lines derived from human grade IV gliomas (GBM and GBM8401). As shown in Figure 1 , Nodal mRNA ( Figure 1a ) and protein ( Figure 1b ) levels were higher in U87MG and GBM8401 cells when compared with that of GBM cells. The expression level of Nodal paralleled with MMP-2 mRNA and protein expressions. The immuno-detected Nodal migrated as a 35-KDa band, which is equivalent to the size of pro-Nodal. The gelatinolytic activities secreted by U87MG and GBM8401 cells were also higher than that secreted by GBM cells (Figure 1c ). In agreement, the capability for cell invasiveness paralleled with the expression levels of Nodal (Figure 1d ). To analyze whether Nodal expression was correlated with glioma tumor growth in vivo, these human glioma cells were intracranially xenografted into the brains of nude mice. The mice were killed at 21 days after the tumor implantation and tumor size was determined. Tumor area, measured by tissue sectioned through their largest diameter, was significantly larger in mice implanted with GBM8401 and U87MG cells than those implanted with GBM cells (Figure 1e ). On the basis of our previous study of in vitro proliferation rates (Jan et al., 2010) , the tumor size were affected partly by the proliferation rate of implanted cell lines.
Recombinant Nodal increased MMP-2 and Nodal expressions and enhanced cell invasiveness in glioma cell lines Nodal is a secreted protein that exerts its function by binding to and bringing together on cell surface types I and II receptors to form a ternary ligand-receptor complex that subsequently regulate cell functions (Hjelmeland et al., 2004; Uhl et al., 2004) . To determine whether exogenously added Nodal would regulate MMP-2 gene expression, we examined the effects of exogenous recombinant Nodal (rNodal) on Nodal and MMP-2 expression in U87MG and GBM cells. Treatments with rNodal (300 ng/ml) increased MMP-2 secretion to the media as determined by zymography analysis (Figure 2a ). Addition of rNodal increased MMP-2 protein expression in GBM cells as determined by western blot analysis (Figure 2b ). Exogenous rNodal significantly increased cell invasiveness of both U87MG and GBM cells (Figure 2c ). Knockdown of MMP-2 by specific shRNA decreased MMP-2 protein levels (shMMP-2 E01 and shMMP-2 F01 in Figure 2d ), and was associated with a marked reduction of in vitro cell invasion in human U87MG glioma cells (Figure 2e ). The addition of rNodal to shMMP-2 clones neither affected MMP-2 protein levels nor significantly increased cell invasiveness when compared with rNodal effects on parental cell lines (Figure 2c ). Taken together, these data suggest that Nodal may mediate MMP-2 secretion and promote cell invasion through an autocrine loop.
Over-expression of Nodal enhanced glioma progression in vitro and in vivo To confirm the role of Nodal in tumor progression, Nodal was stably expressed in less invasive GBM cells. Ectopic expression of Nodal increased Nodal mRNA and protein level in GBM cells (Figures 3a and b) . Overexpression of Nodal was associated with increased MMP-2 mRNA and protein levels (Figures 3a and b) . Over-expression of Nodal in GBM cells also increased the MMP-2 gelatinolytic activity in cultured media (Figure 3c ), the capability for cell invasiveness (Figure 3d ) and the proliferation rate (Figure 3e ). GBM glioma cells bearing Nodal expression vector (pBABE/Nodal) or control vector (pBABE) were implanted in the forebrains of nude mice. At 3 weeks after tumor implantation, the mice were killed and tumor areas were measured by tissue sectioned through their largest diameter (Ma et al., 2002a, b) . As shown in Figure 3f , tumor areas in the brains implanted with GBM/Nodal cells (n ¼ 6) were significantly larger than those implanted with GBM/pBABE cells (n ¼ 6). The Kaplan-Meier plots revealed that mice implanted with GBM/Nodal cells had poor survival rates when compared with mice implanted with GBM/pBABE cells (Figure 3g ).
Nodal knockdown decreased cell invasiveness and tumor growth in vitro and in vivo To explore the possibility that Nodal inhibition can serve as a potential therapeutic strategy in glioma treatment, shRNA specific for Nodal (shNodal) was used to knockdown Nodal expression in the more invasive U87MG cells that expressed higher Nodal level. Transfection of shNodal suppressed Nodal mRNA and protein expression in U87MG cells (Figures 4a and b) . Knockdown of Nodal expression was accompanied by reduction of MMP-2 mRNA and protein levels in U87MG cells (Figures 4a and b) and reduced MMP-2 secretion in the media (Figure 4c ). Knockdown of Nodal expression resulted in decreased cell invasiveness ( Figure 4d ) and lower cell proliferation (Figure 4e) . At day 21, the tumor areas of mice implanted with Nodal knockdown cells (U87MG/shNodal; n ¼ 6) were dramatically reduced when compared with the control U87MG cells (U87MG/pLKO.1; n ¼ 6; Figure 4f ). The Kaplan-Meier plots reveal that mice implanted with Nodal knockdown cells (U87MG/shNodal) had increased lifespan when compared with mice xenografted with U87MG/pLKO.1 cells (n ¼ 6; Figure 4g ).
Nodal enhances glioma invasion in vivo
We next analyzed whether Nodal promotes glioma invasion in vivo. High-magnification photos of hematoxylin and eosin-stained brain tissue sections revealed invasion nests in the surrounding brain tumors of mice implanted with the U87MG/pLKO.1 cells, but not in the brains of mice grafted with Nodal-knockdown U87MG/shNodal cells ( Figure 5a ). Invasion nests were noted in mice brain previously xenografted with GBM/ Nodal cells, but not in the brain tissues grafted with the less invasive GBM/pBABE cells. Tumors that became invasive were associated with Nodal over-expression as showed by immunohistochemical staining. The microphotographs show positive staining of Nodal around the tumor mass and invasion nests of tumor cells in mice brain tissues (Figure 5a ). Taken together, these data suggested that Nodal enhanced glioma invasion in vivo.
It is well known that Nodal regulates cell differentiation in human embryonic stem cells (Besser, 2004; Saha et al., 2008; Smith et al., 2008) . However, the role of Nodal on glioma differentiation remained to be analyzed. An increase in GFAP/vimentin expression ratio is associated with glial cell differentiation and is a diagnostic marker for glioma differentiation. To elucidate whether Nodal regulates the differentiation of glioma cells, we analyzed the protein levels of GFAP and vimentin in cells expressing different levels of Nodal. Figure 5b shows that the protein level of vimentin was high in U87MG/pLKO.1 cells, and the knockdown of Nodal in U87MG/shNodal cells reduced vimentin protein levels. These observations were further confirmed by immunofluorescence micrographs (Figure 5c ). These results suggest that malignant glioma cells can be induced to differentiate by decreasing Nodal expression. In contrast, Nodal over-expression in GBM cells enhanced glioma dedifferentiation from a less malignant phenotype (high GFAP and low vimentin expressions) toward a more invasive phenotype (low GFAP and higher vimentin expressions; Figure 5c ).
Nodal expression is increased in human tissues of high-grade gliomas To investigate the expression levels of Nodal expression in various stages of gliomas, we analyzed the Nodal expression in human tissue sections prepared from different grades of gliomas (grades I-IV). Nodal expression is low in low-grade tumors, but is highly expressed in high-grade glioma sections (Figure 6a ). To confirm that Nodal expression is increased in human gliomas, we analyzed the gene expression profiling of Nodal (Affymetrix probe set 230916, St Clara, CA, USA) in astrocytomas, glioblastomas and oligodendrogliomas compared with non-tumor brain tissue counterparts from the public microarray repository database, Gene Expression Omnibus/GSE4290 (Phillips et al., 2006; Sun et al., 2006) . Nodal expression levels are significantly higher in astrocytomas, glioblastomas, and oligodendrogliomas compared with non-tumor tissues (one-way analysis of variance, Po0.001, Figure 6b upper panel). Furthermore, higher Nodal expression levels were noted in WHO (World Health Organization) grade IV gliomas when compared with the less malignant grade III astrocytomas in GSE4271 microarray data (Po0.001, Figure 6b lower panel) (Phillips et al., 2006) . These results suggest that Nodal expression is positively correlated with tumor malignancy.
Nodal may promote glioma oncogenesis through the activation of Smad pathway and induction of LIF Recently, TGF-b has been shown to induce self-renewal of glioma cells through induction of LIF and Cripto-1 through an activated Smad complex (Mancino et al., 2008; Penuelas et al., 2009) 
Discussion
In this study we analyzed the roles of Nodal in the invasiveness of human glioma cells. We showed that Nodal is highly expressed in malignant human glioma cells. We also showed that the treatment of glioma cells with rNodal enhanced Nodal protein expression, suggesting that an autocrine loop may be involved in the malignant progression of gliomas. In addition, we showed that the addition of rNodal to glioma cells increased MMP-2 secretion and enhanced glioma cell invasion. In contrast, the knockdown of Nodal by specific shRNA in U87MG cells reduced MMP-2 secretion and cell invasiveness. Mice implanted with Nodal-knockdown cells survived longer than those implanted with control U87MG cells.
Nodal has a central role in embryonic morphogenesis and tumor progression (Topczewska et al., 2006; Bennett et al., 2007) . Similar to Nodal, MMP-2 has also been implicated in embryogenesis and tumor invasion (Rooprai et al., 2000) . In this study, we showed that the ectopic expression of Nodal or activation of Nodal signaling by addition of rNodal increased MMP-2 protein level and cell invasion. In contrast, the knockdown of Nodal expression in U87MG glioma cells with high Nodal expression level has reduced MMP-2 secretion and invasion. Thus, the expression level of Nodal correlates well with MMP-2 expression and cell invasion. Indeed, knockdown of MMP-2 expression by specific shRNA abolished rNodal-stimulated cell invasion, suggesting that Nodal mediates cell invasion, at least in part, through MMP-2 secretion.
An increase in intermediate filament protein, vimentin, enables cancer cells to invade adjacent tissues; vimentin is considered an aggressive phenotype marker in gliomas. We showed that the over-expression of Nodal increased vimentin expression and increased the capability of cell invasion in glioma cells. These data agree with the previous report that vimentin is induced by TGF-b treatment in glioma cell lines (Wick et al., 2006) . Another change accompanying the malignant progression of glioma is the decrease in GFAP expression. GFAP is also an intermediate filament protein that is among the best marker of astrocytic differentiation (Rutka et al., 1997; Zhou and Skalli, 2000) . Increased GFAP and decreased vimentin expression are the hallmarks of glial cell differentiation (Rutka et al., 1997; Svechnikova et al., 2008) . We showed that the knockdown of Nodal expression by specific shRNA increased GFAP expression in U87MG cells and that Nodal over-expression is associated with a decrease in GFAP protein level, suggesting that Nodal may have a role in preventing tumor cell differentiation. These results are consistent with the report that TGF-a suppresses GFAP mRNA and protein expression in U373MG glioblastoma cells (Zhou and Skalli, 2000) .
In fact, Nodal is not only crucial in cell invasion, but also mediates multi-potent, plastic phenotypes and other stem cell-like properties in human melanoma (Topczewska et al., 2006) . Recently, Penuelas et al. (2009) reported that TGF-b induces self-renewal and prevents differentiation of glioma cells through induction of LIF. In addition to LIF, the expression of Cripto-1 is also relevant to cancer stem cells in malignant tumors . In this study we showed that Nodal regulated LIF and Cripto-1 expressions in glioma cells through receptor-mediated pathway in glioma cells. It has been well documented that Nodal mediates its signal through the SMAD2/3-dependent pathway that regulates melanoma plasticity (Hendrix et al., 2007; Postovit et al., 2008a, b) . We showed that treatment with rNodal or forced expression of Nodal in GBM cells increased This study shows that the over-expression of Nodal significantly increased tumor size and shortened the lifespan of mice xenografted with GBM cells. Conversely, the knockdown of Nodal by specific shRNA in U87MG cells prolonged the lifespan of mice xenografted with U87MG cells. Taken together, these results suggest that the expression levels of Nodal correlated well with the malignancy of gliomas in vitro and in vivo and support the notion that Nodal can be considered as a diagnostic marker for tumor progression. In addition, we show that the inhibition of Nodal signaling may reduce glioma cell invasiveness and prolong the lifespan of mice implanted with malignant U87MG glioma cells. These results support the notion that inhibition of Nodal signaling may be considered as a novel therapeutic strategy in glioma treatment.
Materials and methods

Materials
Dulbecco's modified Eagle's medium (DMEM), fetal calf serum, glutamine, gentamycin, penicillin and streptomycin were purchased from Life Technologies (Gaithersburg, MD, USA). Antibody specific for MMP-2 was purchased from Sigma Chemical (St Louis, MO, USA). Anti-Nodal antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA; Cat. no. SC-28913). Recombinant Nodal (rNodal) was purchased from R&D Systems (Minneapolis, MN, USA). Horseradish peroxidase-conjugated anti-rabbit immunoglobulin G antibody was purchased from Bio-Rad (Hercules, CA, USA). RNAsin ribonuclease inhibitor and Moloney murine leukemia virus reverse transcriptase were purchased from Promega (Madison, WI, USA). Protease inhibitor cocktail tablets were purchased from Boehringer Mannheim (Mannheim, Germany).
Patient samples
The tissue sections were obtained from archived specimens of patients who underwent gliomas operations at Shin Kong Memorial Hospital, Taipei, Taiwan.
Cell cultures
Human U87MG (American Type Culture Collection no. HTB-14), GBM8401 and GBM glioma cells were cultured in DMEM supplemented with 10% heat-inactivated fetal calf serum. At the end of treatment incubations, cells were lysed by # indicates the number of patient samples. The bottom and top of the boxes are the 25th and 75th percentiles, respectively, and the ends of the whiskers represent the minimum and maximum of used data. J and * denote the outliers in respective data. adding lysis buffer containing 10 mM Tris-HCl (pH 7.5), 1 mM ethylene glycol tetraacetic acid, 1 mM MgCl 2 , 1 mM sodium orthovanadate, 1 mM dithiothreitol, 0.1% mercaptoethanol, 0.5% Triton X-100 and protease inhibitor cocktails (with final concentrations of 0.2 mM phenylmethylsulfonyl fluoride, 0.1% aprotinin and 50 mg/ml leupeptin), and then stored at À70 1C for further measurements.
Western blots
Proteins were separated by 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis. After electrophoresis, proteins on the gel were electro-transferred onto a polyvinyldifluoride membrane. This membrane was blotted with primary antibodies in blocking buffer, and then washed in 1% Tween-20 in phosphate-buffered saline (pH 7.4). The polyvinyldifluoride membrane was incubated with peroxidase-linked antimouse immunoglobulin G antibodies for 1 h and then developed using an enhanced chemiluminescence plus detection kit (Amersham Life Sciences, Piscataway, NJ, USA).
Gelatin zymography
Gelatinolytic zymography was used to detect the secretion of MMP-2 in serum-free culture media. After treatment, the collected media (15 ml) was loaded onto 10% SDS-polyacrylamide gels co-polymerized with 0.1% gelatin and subjected to electrophoresis. The electrophoresed gel was washed twice with 2.5% Triton X-100 solution for 30 min each, rinsed with incubation buffer (0.05 M Tris-HCl buffer pH 8.0, 5 mM CaCl 2 and 5 mM ZnCl 2 ), and incubated at 37 1C overnight. The gel was stained at room temperature until the lysis bands became clear. Gelatinase activities in the media were detected as unstained gelatin-degraded zones on the gel. The MMP-2-relative photographic density was quantitated by scanning the photographic negatives on a gel analysis system (BioSpectrum AC Imaging System Vision with LS software, Upland, CA, USA).
Plasmid transfections
For the ectopical expression of Nodal, GBM cells were seeded in 6-cm dish. The next day, pBABE/Nodal or pBABE vector control were each transfected into cells using Lipofectamine (Carlsbad, CA, USA). After 24 h, the medium was changed to select for puromycin-resistant clones. Parallel treatments were collected for western blot analysis and reverse transcriptase-PCR. For the knockdown of gene expressions, U87MG cells were seeded at 5 Â 10 5 cells per 6-cm dish and allowed to adhere overnight. The next day, Nodal-specific small hairpin RNA plasmid (shNodal, TRCN0000058699; oligo sequence: 5 0 -CCGGGCGGTTTC AGATGGACCTATTCTCGAGAATAGGTCCATCTGAAA CCGCTTTTTG-3 0 ) or the PLKO.1 vector control was transfected into cells using Lipofectamine. Puromycin was used for stable clone selection. Two separate U87MG clones with MMP2-specific small hairpin RNA plasmids (shMMP-2 E01, TRCN0000051526; oligo sequence: 5 0 -CCGGGCAGAC ATCATGATCAACTTTCTCGAGAAAGTTGATCATGAT GTCTGCTTTTTG-3 0 and shMMP-2 F01, TRCN0000051527; 5 0 -CCGGCCAAAGTCTGAAGAGCGTGAACTCGAGT TCACGCTCTTCAGACTTTGGTTTTTG-3 0 ) were also selected in the same manner. All shRNA plasmids and the control vector were from the RNAi Consortium and obtained from Academia Sinica, Taipei, Taiwan.
Total RNA isolation and reverse transcriptase-PCR Total RNA was extracted from monolayer of cultured glioma cells using TRIzol reagent. Reverse transcription was carried out in reaction mixture at 65 1C for 5 min and then at 42 1C for 50 min. The reaction was stopped by incubation of the reaction mixture at 70 1C for 15 min. Primers for MMP-2 (forward, 5 0 -GAGTTGGCAGTGCAATACCT-3 0 ; reverse, 5 0 -GCCGT CCTTCTCAAAGTTGT -3 0 ), for Nodal (forward, 5 0 -AGA AGCAGATGTCCAGGGTAGC-3 0 ; reverse, 5 0 -AGAGGCA CCCACATTCTTCC-3 0 ) and for glyceraldehyde 3-phosphate dehydrogenase (forward, 5 0 -GCCAAAAGGGTCATCATC TCTG-3 0 ; reverse, 5 0 -CATGCCAGTGAGCTTCCCGT-3 0 ) were derived from human sequences, and PCR conditions optimized so that the gene products were in the exponential phase of the amplification.
In vitro invasion assay (Boyden chamber) Matrigel invasion assays were performed with a cell invasion assay kit (BD Biosciences, Mansfield, MA, USA). Cells (2 Â 10 5 ) suspended in serum-free DMEM with various treatments were placed in the upper compartment of each chamber. Lower compartments were filled with DMEM that contained 10% fetal bovine serum. After 24 h of incubation, non-invading cells were gently removed. Cells that had migrated to the lower side of the membranes were fixed, stained with toluidine blue solution (Sigma-Aldrich, St Louis, MO, USA) and counted.
Dye exclusion assay
Glioma cells grown on 150-mm plates were washed twice with phosphate-buffered saline (PBS) and resuspended in DMEM. The suspended cells were plated on 24-well plates (2 Â 104 cells/well). Viable cell numbers were counted at various time points. Cells were rinsed with PBS before incubation with trypsin. The trypsinized cells were then washed, resuspended in Trypan blue (0.4%), and counted for live cells on a hemocytometer. Treatment for each group was performed in triplicate.
Immunofluorescence staining Cells were seeded on glass coverslip and incubated at 37 1C overnight before treatments. After a period of incubation, treated cells were washed with cold PBS and then fixed with pre-chilled methanol (À20 1C) for 20 min. After blocking with 1% bovine serum albumin in PBS, cells were then incubated with primary antibodies (1 mg/ml) at room temperature for 1 h in a moist container in the dark. The glass coverslip was washed with PBS three times, and then the Alexa Fluorconjugated secondary antibodies against mouse (A21127) or rabbit (A31572) immunoglobulin Gs (Invitrogen Corp., Carlsbad, CA, USA) were added on each glass coverslip and incubated at room temperature for 1 h in a moist container in the dark. The coverslips were mounted in 30% glycerol onto a slide and observed under a fluorescence microscope.
In vivo intracranial xenografts Cells were freshly prepared and adjusted to 1 Â 10 5 cells/ml before implantation. The intracranial xenografts were performed according to the protocols approved by the Institutional Animal Care and Use Committee. In brief, nude mice were anesthetized and placed in a stereotactic frame, and the skull was exposed. A hole was made 3 mm to the right of the bregma, and cells (5 ml) were injected using a 10-ml Hamilton syringe with a 26s-gauge needle mounted in a stereotactic holder (Bonaduz, GR, Switzerland). The syringe was lowered to a depth of 3.5 mm and then raised to a depth of 2.5 mm. The glioma cells were injected at a rate of 0.5 ml/10 s. Tumors were allowed to grow, and animals were killed on day 21, or when the animals developed signs of neurological deficit (Ma et al., 2002a, b) . The mice were perfused, and the extracted brains were postfixed in 4% paraformaldehyde overnight, and then embedded in paraffin for further analysis. Formalin-fixed, paraffin-embedded tissue sections were dewaxed in xylene for 10 min, rehydrated in alcohol solution and stained with hematoxylin and eosin. The sizes of brain tumors were microscopically determined as described by Ma et al. (2002a, b) .
Immunohistochemical staining
Formalin-fixed, paraffin-embedded tissue sections were used for examining the expression of Nodal protein. In brief, 4-6 mm thick sections were cut using a microtome and applied to slides coated with poly-L-lysine. Sections were dewaxed in xylene for 10 min, rehydrated in alcohol solution and placed in 5% hydrogen peroxide in absolute alcohol for 10 min to block endogenous peroxidase activity. To unmask antigen by heat treatment, the slides were placed in a container and covered with 10 mM sodium citrate buffer, pH 6 and heated at 95 1C for 5 min. The primary antibody was diluted (1:50) and added in sufficient volume to cover this tissue, and then incubated for 2 h. Slides were rinsed with PBS and washed in PBS twice for 2 min each on a stir plate. The sections were incubated for 30 min in biotinylated secondary antibody at a dilution of 1:200. They were then rinsed with PBS, and then washed with PBS twice for 2 min each on stir plate. Tissue sections were then incubated with horseradish peroxidase-streptavidin complex (Dako, Glostrup, Denmark) for 30 min before washing again with PBS. The immunostaining was visualized by developing in diaminobenzidine before counterstaining with Mayer's hematoxylin and eosin stain.
Statistical analysis
Results are expressed as the mean ± s.e.m. for the number of independent experiments performed. One-way analysis of variance was used to assess the difference of means among groups, and Student's two-tailed t-test was used to determine the difference of means between any two groups. A P-value of o0.05 was taken as statistically significant.
Microarray data downloaded from the Gene Expression Omnibus at the National Center for Biotechnology Information website were analyzed using SPSS 13 and visualized using Box plots (Chicago, IL, USA).
